仅仅是触及表面：靶向细胞膜蛋白的多发性骨髓瘤新型治疗方法
Just scratching the surface: novel treatment approaches for multiple myeloma targeting cell membrane proteins.
64.0分
★★★☆☆
站内排序·非疗效
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
ALL SOURCES
全部资讯 11
ide-cel 早期复发后 BCMA 靶向双特异性抗体治疗结局不佳：一项法国真实世界研究
Poor outcomes with BCMA-targeting bispecific antibodies following early relapse from ide-cel: a real-world French study.
63.4分
★★★☆☆
站内排序·非疗效
多发性骨髓瘤中 CAR-T 或 BiTE 治疗的患者选择：每位患者应选择哪种治疗？
Patient selection for CAR T or BiTE therapy in multiple myeloma: Which treatment for each patient?
62.5分
★★★☆☆
站内排序·非疗效
多发性骨髓瘤中的双特异性抗体：通过合理联合治疗最大化潜力
Bispecific antibodies in multiple myeloma: maximizing potential through rational combination therapies.
57.4分
★★★☆☆
站内排序·非疗效
超越骨髓：髓外多发性骨髓瘤肿瘤综合下一代测序的见解
Beyond the marrow: insights from comprehensive next-generation sequencing of extramedullary multiple myeloma tumors.
48.0分
★★★☆☆
站内排序·非疗效
双特异性抗体在多发性骨髓瘤中的演进
The evolution of bispecific antibodies in multiple myeloma.
46.3分
★★★☆☆
站内排序·非疗效
我们到了吗？多发性骨髓瘤中的 CAR-T 治疗
Are we there yet? CAR-T therapy in multiple myeloma.
33.9分
★☆☆☆☆
站内排序·非疗效
双特异性抗体治疗复发/难治性多发性骨髓瘤：更新与未来展望
Bispecific antibodies for the treatment of relapsed/refractory multiple myeloma: updates and future perspectives.
32.4分
★☆☆☆☆
站内排序·非疗效
BCMA 之外的多发性骨髓瘤 T 细胞重定向双特异性与三特异性抗体
T-cell redirecting bispecific and trispecific antibodies in multiple myeloma beyond BCMA.
31.6分
★☆☆☆☆
站内排序·非疗效
多发性骨髓瘤靶向免疫治疗新前沿的潜力抗原
Promising Antigens for the New Frontier of Targeted Immunotherapy in Multiple Myeloma.
31.3分
★☆☆☆☆
站内排序·非疗效